{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05822609",
            "orgStudyIdInfo": {
                "id": "STUDY00016349"
            },
            "organization": {
                "fullName": "University of Washington",
                "class": "OTHER"
            },
            "briefTitle": "Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes",
            "officialTitle": "Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes",
            "acronym": "RT1D",
            "therapeuticArea": [
                "Endocrinology",
                "Nephrology and Renal Diseases"
            ],
            "study": "trial-of-semaglutide-for-diabetic-kidney-disease-in-type-diabetes"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-05",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-03-24",
            "studyFirstSubmitQcDate": "2023-04-18",
            "studyFirstPostDateStruct": {
                "date": "2023-04-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-04",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Ian deBoer",
                "investigatorTitle": "Professor, School of Medicine",
                "investigatorAffiliation": "University of Washington"
            },
            "leadSponsor": {
                "name": "University of Washington",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Juvenile Diabetes Research Foundation",
                    "class": "OTHER"
                },
                {
                    "name": "University of Colorado, Denver",
                    "class": "OTHER"
                },
                {
                    "name": "Providence Healthcare",
                    "class": "OTHER"
                },
                {
                    "name": "University of Toronto",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The primary objective of this study is to determine the effects of semaglutide on kidney oxygenation and function in type 1 diabetes. The secondary objective is to determine the glycemic effects and safety of semaglutide in type 1 diabetes.",
            "detailedDescription": "A parallel-group, double-blind, placebo-controlled, randomized study will rigorously test effects of semaglutide on the kidney. Real-time continuous glucose monitoring will be used to control glycemia during study run-in (prior to randomization) and during active therapy, which investigators anticipate will lead to similar glycemic control according to treatment assignment and ability to assess effects independent of glycemia. The trial duration is 26 weeks, a period of time sufficient to gradually titrate study medications to maximum target dose (over 12 weeks) and then observe the full short-term effect of semaglutide on the kidney.\n\nStudy Aims and Hypotheses:\n\nAim 1: Determine the effects of semaglutide vs. placebo on kidney oxygenation in type 1 diabetes. Hypothesis 1: Semaglutide will improve kidney oxygen availability in adults with type 1 diabetes.\n\nAim 2: Determine the effects of semaglutide vs. placebo on urine albumin-creatinine ratio and estimated glomerular filtration rate in type 1 diabetes. Hypothesis 2: Semaglutide will lower albuminuria and slow estimated glomerular filtration rate decline in adults with type 1 diabetes.\n\nAim 3: Determine the glycemic effects and safety of semaglutide vs. placebo in type 1 diabetes. Hypothesis 3: Semaglutide will reduce total daily insulin dose and improve glycemic variability without increasing risk of severe hypoglycemia or diabetic ketoacidosis in adults with type 1 diabetes."
        },
        "conditionsModule": {
            "conditions": [
                "Diabetic Kidney Disease",
                "Type 1 Diabetes"
            ],
            "keywords": [
                "Glucagon-like peptide-1 receptor agonist"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Semaglutide",
                    "type": "EXPERIMENTAL",
                    "description": "Semaglutide group from 0.25mg to 1.0mg",
                    "interventionNames": [
                        "Drug: Semaglutide"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo group",
                    "interventionNames": [
                        "Other: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Semaglutide",
                    "description": "1.0 mg",
                    "armGroupLabels": [
                        "Semaglutide"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo",
                    "description": "Placebo",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in kidney cortical relaxation rates (R2*)",
                    "description": "Measurement of oxygenation by magnetic resonance imaging",
                    "timeFrame": "Baseline to 26 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in urine albumin excretion",
                    "description": "Measured as mean of multiple urine albumin-creatinine ratio measurements in spot urine",
                    "timeFrame": "Baseline to 26 weeks"
                },
                {
                    "measure": "Change in estimated glomerular filtration rate",
                    "description": "Estimated glomerular filtration rate will be calculated from age, sex, and the serum concentrations of creatinine and cystatin C",
                    "timeFrame": "Baseline to 26 weeks"
                },
                {
                    "measure": "Change in glucose time in range",
                    "description": "Proportion of time with glucose 70-180 mg/dL measured by continuous glucose monitoring",
                    "timeFrame": "Baseline to 26 weeks"
                },
                {
                    "measure": "Change in glucose coefficient of variation",
                    "description": "Measured by continuous glucose monitoring",
                    "timeFrame": "Baseline to 26 weeks"
                },
                {
                    "measure": "Change in total daily insulin dose",
                    "description": "Mean total dose of insulin administered per day",
                    "timeFrame": "Baseline to 26 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adults (\u226518 years) with type 1 diabetes\n* Diabetes duration of \u22655 years\n* Persistent urine albumin-to-creatinine ratio (UACR) \u2265 30 mg/g, on the most recent two measurements within the prior 3 years\n* Estimated glomerular filtration rate \u2265 45 mL/min/1.73m2\n* Stable doses of drugs altering blood pressure (e.g., Angiotensin-converting enzyme inhibitor) required for at least 4 weeks prior to randomization, and requested for the duration of the trial\n* Stable doses of lipid-lowering medications required for at least 4 weeks prior to randomization, and requested for the duration of the trial\n* Adequate contraceptive method for females of child-bearing potential\n\nExclusion Criteria:\n\n* HbA1c \\>9%, recent diabetic ketoacidosis, hyperosmolar hyperglycemic state or severe illness requiring hospitalization in past 30 days\n* Other causes of diabetes mellitus, including type 2 diabetes and maturity-onset diabetes of the young (MODY)\n* Chronic kidney disease unrelated to diabetes\n* Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) or thyroid nodule palpated by endocrinologist at screening\n* Personal history of pancreatitis\n* Current/planned pregnancy or nursing\n* Uncontrolled thyroid disease or hypertension (Systolic blood pressure \\[SBP\\] \u2265 160 mm Hg or diastolic blood pressure \\[DBP\\] \u2265 100 mm Hg despite treatment)\n* Proliferative retinopathy with treatment in the past 6 months\n* Uncontrolled or potentially unstable diabetic retinopathy or maculopathy, verified by fundus examination with pupil dilation unless performed using a digital fundus photography camera specified for non-dilated examination\n* More than 2 severe hypoglycemic episodes (requiring glucagon and/or assistance from another person) in the past 6 months\n* Frequent hypoglycemia during the last two weeks of the study run-in phase (time below range \\[\\<70 mg/dL\\] \u22654%)\n* Pramlintide and the use of glycemia treatments not approved for type 1 diabetes by the FDA, e.g., metformin, SGT-2 inhibitor, GLP-1 receptor agonist, closed loop insulin delivery using unapproved algorithms\n* Significant systemic conditions or treatment such as cancer or immunomodulators\n* Known liver disease other than non-alcoholic fatty liver disease (NAFLD) or aspartate aminotransferase (AST) or alanine aminotransferase (ALT) \\>100 IU/L, history of severe gastrointestinal disease (e.g., gastroparesis) or gallstones\n* Body mass index \\<20 kg/m2\n* Inability to cooperate with or clinical contraindication for magnetic resonance imaging including severe claustrophobia, nonremovable devices, implanted metal\n* Known or suspected allergy/sensitivity to semaglutide or its excipients\n* Pregnant, breast feeding, or the intention of becoming pregnant\n* The receipt of any investigational drug within 3 months prior to this trial\n* Previously randomized in this trial",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Julie Porter",
                    "role": "CONTACT",
                    "phone": "206-897-4728",
                    "email": "jporter7@uw.edu"
                },
                {
                    "name": "Ernest Ayers, MSPH",
                    "role": "CONTACT",
                    "phone": "206-685-1423",
                    "email": "ayerse@uw.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Ian de Boer, MD, MS",
                    "affiliation": "University of Washington",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Jessica Kendrick, MD",
                    "affiliation": "University of Colorado Anschutz Medical Campus and Children's Hospital Colorado",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "David Cherney, PhD, MD",
                    "affiliation": "University of Toronto",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Irl Hirsch, MD",
                    "affiliation": "University of Washington",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Katherine Tuttle, MD",
                    "affiliation": "Providence Healthcare",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Colorado Anschutz Medical Campus",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Madeline Harbour, BA",
                            "role": "CONTACT",
                            "phone": "720-689-4751",
                            "email": "madeline.harbour@childrenscolorado.org"
                        },
                        {
                            "name": "Carissa Birznieks, BS",
                            "role": "CONTACT",
                            "phone": "720-689-4751",
                            "email": "carissa.birznieks@cuanschutz.edu"
                        },
                        {
                            "name": "Jessica Kendrick, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "University of Washington",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Evelin Jones",
                            "role": "CONTACT",
                            "phone": "206-945-4965",
                            "email": "evelinj@nephrology.washington.edu"
                        },
                        {
                            "name": "Dori Khakpour, RDN CDE",
                            "role": "CONTACT",
                            "phone": "206-945-4954",
                            "email": "dorik@uw.edu"
                        },
                        {
                            "name": "Irl Hirsch, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "Providence Sacred Heart Medical Center",
                    "status": "RECRUITING",
                    "city": "Spokane",
                    "state": "Washington",
                    "zip": "99204",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nicole Maser, MSN RN",
                            "role": "CONTACT",
                            "phone": "509-474-5313",
                            "email": "nicole.maser@providence.org"
                        },
                        {
                            "name": "Susan Hood, PhD CCRC",
                            "role": "CONTACT",
                            "phone": "509-474-4224",
                            "email": "susan.hood@providence.org"
                        },
                        {
                            "name": "Katherine Tuttle, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.65966,
                        "lon": -117.42908
                    }
                },
                {
                    "facility": "Toronto General Hospital, University Health Network",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M5G2N2",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Vesta Lai",
                            "role": "CONTACT",
                            "phone": "416-340-4800",
                            "phoneExt": "8508",
                            "email": "vesta.lai@uhn.ca"
                        },
                        {
                            "name": "Cheng Xu",
                            "role": "CONTACT",
                            "phone": "416-340-4800",
                            "phoneExt": "8508",
                            "email": "cheng.xu@uhn.ca"
                        },
                        {
                            "name": "David Cherney, MD CM PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "The study team will field direct requests from other researchers to share deidentified data after completion of the trial.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF"
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000003928",
                    "term": "Diabetic Nephropathies"
                },
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000003922",
                    "term": "Diabetes Mellitus, Type 1"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000048909",
                    "term": "Diabetes Complications"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "asFound": "Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7117",
                    "name": "Diabetes Mellitus, Type 1",
                    "asFound": "Type 1 Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "asFound": "Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7123",
                    "name": "Diabetic Nephropathies",
                    "asFound": "Diabetic Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M26004",
                    "name": "Diabetes Complications",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000591245",
                    "term": "Semaglutide"
                }
            ],
            "ancestors": [
                {
                    "id": "D000097789",
                    "term": "Glucagon-Like Peptide-1 Receptor Agonists"
                },
                {
                    "id": "D000007004",
                    "term": "Hypoglycemic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9043",
                    "name": "Glucagon",
                    "relevance": "LOW"
                },
                {
                    "id": "M26997",
                    "name": "Glucagon-Like Peptide 1",
                    "relevance": "LOW"
                },
                {
                    "id": "M353561",
                    "name": "Semaglutide",
                    "asFound": "Stretching",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3401",
                    "name": "Glucagon-Like Peptide-1 Receptor Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M10054",
                    "name": "Hypoglycemic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                }
            ]
        }
    },
    "hasResults": false
}